Sign In
Free Newsletter
Cellares to manufacture Cabaletta CAR-T under 10-year deal
The 10-year deal will enable automated, large-scale production for autoimmune diseases with Cabaletta Bio's rese-cel therapy.
Cellares, Cabaletta achieve CAR T dosing milestone
Cellares and Cabaletta Bio dose first patients with CAR T therapy using automated Cell Shuttle platform, marking a key clinical milestone.
Novartis to acquire Synnovation’s breast cancer drug for $2B
The addition of Synnovation’s experimental treatment aims to expand Novartis' oncology portfolio as well as improve precision medicine options.
HMH Emerge names 3 global health tech winners
The collaboration with Choose New Jersey picked three startups focused on cardiovascular innovation to scale operations in the U.S. with funding, mentorship and clinical trial support.
BioNJ unveils roadmap to boost NJ life sciences leadership
BioNJ released a white paper outlining an eight-year strategy to enhance New Jersey's life sciences sector by elevating its profile, strengthening startups, attracting talent, boosting manufacturing and expanding into adjacent sectors.
BioNJ, Medidata tackle underrepresentation in clinical trials
The life sciences trade association and the data analytics firm studied New Jersey's recruitment performance by comparing it with similar northeastern states based on comparable demographic, infrastructural and geographical factors.
Atlantic Health marks milestone in lupus treatment trial
The study recently enrolled its first U.S. patient.
BioNJ names 3 winners at health equity-focused case competition (slideshow)
The first-ever event from the state's life sciences trade association recognized three teams, including one from New Jersey, and awarded more than $20,000 in prize money.
BioNJ launches initiative to facilitate equity in clinical trials
The life sciences trade organization said the effort will help to identify issues and interventions, offer support to companies and benchmark best practices. Additionally, it will aim to influence the next generation of field innovators through a MBA Business Plan Case Competition.
